Acquisition · 2026-10-20 · AI

Orchestra Bio Inc. acquisition (Undisclosed)

AI Score

Amount

Undisclosed

Round

Acquisition

Lead

Not disclosed

San Francisco, CA, US

Why it matters: The deal shows how OpenAI plans to apply its Rosalind biology models to the slow, fragmented drug development pipeline, and it sits alongside Anthropic's own biotech acquisition.

OpenAI Group PBC has acquired Orchestra Bio, a San Francisco startup whose AI agents help pharmaceutical teams track development programs.

Participants:: —
Source:: SiliconANGLE ↗ · Midu summary

Deal Dossier PRO

Pro feature

Deal Dossier for Orchestra Bio Inc.

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro

Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

Recent AI rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

Midu WeeklyMondays · funding trends and top roundsSee a sample issue →SF WeeklyFridays · San Francisco startups, rounds and eventsSee a sample issue →

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing